Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1998 | 06-1998 | 03-1998 | 12-1997 | 09-1997 | |
| Gross Profit | 14,000 | 14,910 | 13,920 | 33,244 | N/A |
| Operating Expenses | 3,030 | 3,190 | 3,200 | 3,369 | 2,410 |
| Operating Income | -3,030 | -3,190 | -3,200 | -3,369 | -2,410 |
| Pre-tax Income | -3,030 | -3,190 | -3,200 | -3,369 | -2,410 |
| Net Income Continuous | -3,030 | -3,190 | -3,200 | -3,369 | -2,410 |
| Net Income | $-3,030 | $-3,190 | $-3,200 | $-3,369 | $-2,410 |
| EBITDA(a) | $-940 | $-1,550 | $-1,580 | $-3,369 | $-2,410 |